These benefits, along with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two support the thought of focusing on ACKR3 as a singular way to modulate the opioid procedure, which could open new therapeutic avenues for opioid-rela